Pulike Biological Engineering, Inc. (603566.SS)
CNY 12.25
(0.41%)
CNY 12.25
(0.41%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -315.16 Million CNY | -15.11% |
| 2022 | -273.79 Million CNY | -62.17% |
| 2021 | -168.83 Million CNY | 33.44% |
| 2020 | -253.65 Million CNY | 14.34% |
| 2019 | -296.1 Million CNY | 32.5% |
| 2018 | -438.65 Million CNY | -85.49% |
| 2017 | -236.48 Million CNY | 38.24% |
| 2016 | -382.88 Million CNY | 2.12% |
| 2015 | -391.17 Million CNY | -83.19% |
| 2014 | -213.53 Million CNY | -26.85% |
| 2013 | -168.33 Million CNY | -56.57% |
| 2012 | -107.51 Million CNY | -125.42% |
| 2011 | -47.69 Million CNY | 54.77% |
| 2010 | -105.45 Million CNY | -1.2% |
| 2009 | -104.19 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -198.35 Million CNY | 38.77% |
| 2024 Q1 | -157.83 Million CNY | 49.92% |
| 2024 Q2 | -323.92 Million CNY | -105.22% |
| 2023 Q4 | -315.16 Million CNY | -8.0% |
| 2023 Q1 | -311.53 Million CNY | -13.78% |
| 2023 FY | -315.16 Million CNY | -15.11% |
| 2023 Q3 | -291.82 Million CNY | -36.21% |
| 2023 Q2 | -214.25 Million CNY | 31.23% |
| 2022 Q1 | -210.95 Million CNY | -24.95% |
| 2022 Q4 | -273.79 Million CNY | 74.03% |
| 2022 FY | -273.79 Million CNY | -62.17% |
| 2022 Q3 | -1.05 Billion CNY | -477.96% |
| 2022 Q2 | -182.41 Million CNY | 13.53% |
| 2021 Q1 | -186.2 Million CNY | 26.59% |
| 2021 Q3 | -250.41 Million CNY | -70.03% |
| 2021 Q2 | -147.27 Million CNY | 20.91% |
| 2021 Q4 | -168.83 Million CNY | 32.58% |
| 2021 FY | -168.83 Million CNY | 33.44% |
| 2020 Q4 | -253.65 Million CNY | -18.49% |
| 2020 FY | -253.65 Million CNY | 14.34% |
| 2020 Q2 | -260.89 Million CNY | 30.43% |
| 2020 Q3 | -214.07 Million CNY | 17.95% |
| 2020 Q1 | -375.01 Million CNY | -26.65% |
| 2019 Q4 | -296.1 Million CNY | -21.83% |
| 2019 Q1 | -313.99 Million CNY | 30.43% |
| 2019 Q2 | -171.1 Million CNY | 45.51% |
| 2019 Q3 | -243.04 Million CNY | -42.04% |
| 2019 FY | -296.1 Million CNY | 32.5% |
| 2018 Q1 | -238.59 Million CNY | 9.45% |
| 2018 FY | -438.65 Million CNY | -85.49% |
| 2018 Q4 | -451.36 Million CNY | -118.91% |
| 2018 Q3 | -206.18 Million CNY | 23.48% |
| 2018 Q2 | -269.47 Million CNY | -12.94% |
| 2017 Q2 | -184.58 Million CNY | 49.34% |
| 2017 Q3 | -193.77 Million CNY | -4.98% |
| 2017 Q4 | -263.48 Million CNY | -35.97% |
| 2017 FY | -236.48 Million CNY | 38.24% |
| 2017 Q1 | -364.34 Million CNY | 15.0% |
| 2016 Q2 | -254.16 Million CNY | 36.9% |
| 2016 Q1 | -402.81 Million CNY | -2.98% |
| 2016 Q4 | -428.62 Million CNY | -62.61% |
| 2016 Q3 | -263.59 Million CNY | -3.71% |
| 2016 FY | -382.88 Million CNY | 2.12% |
| 2015 Q1 | 213.53 Million CNY | 200.0% |
| 2015 Q4 | -391.17 Million CNY | 5.78% |
| 2015 Q3 | -415.16 Million CNY | 46.81% |
| 2015 Q2 | -780.53 Million CNY | -465.53% |
| 2015 FY | -391.17 Million CNY | -83.19% |
| 2014 Q4 | -213.53 Million CNY | 0.0% |
| 2014 FY | -213.53 Million CNY | -26.85% |
| 2014 Q1 | 168.33 Million CNY | 0.0% |
| 2013 FY | -168.33 Million CNY | -56.57% |
| 2012 FY | -107.51 Million CNY | -125.42% |
| 2011 FY | -47.69 Million CNY | 54.77% |
| 2010 FY | -105.45 Million CNY | -1.2% |
| 2009 FY | -104.19 Million CNY | 0.0% |